Daxor Corporation  

(Public, NYSEAMERICAN:DXR)   Watch this stock  
Find more results for DXR
-0.22 (-5.70%)
Real-time:   10:11AM EST
NYSEAMERICAN real-time data - Disclaimer
Currency in USD
Range 3.64 - 3.64
52 week 3.64 - 9.20
Open 3.64
Vol / Avg. 941.00/3,890.00
Mkt cap 13.80M
P/E     -
Div/yield 0.03/0.82
EPS -0.21
Shares 3.79M
Beta 0.15
Inst. own 3%

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -218.59% 272.81%
Operating margin 53.89% 24.05%
EBITD margin - 24.05%
Return on average assets -5.82% 7.01%
Return on average equity -8.02% 9.78%
Employees 37 -
CDP Score - -


350 5th Ave Ste 4740
NEW YORK, NY 10118-0002
United States - Map
+1-212-3308500 (Phone)
+1-212-2440806 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company engages in the short selling of stock. The Company maintains a diversified securities portfolio, which consists primarily of the common and preferred stocks of electric utility companies. It has approximately 70 Blood Volume Analyzers (BVA)-100. It also sells Volumex Kits. The semi-automated BVA provides blood volume measurements in human body, which are fundamental tools for diagnosis and treatment in a range of medical and surgical conditions, including congestive heart failure, hypertension, syncope, anemia in cancer patients, kidney failure and hyponatremia. The BVA-100 measures blood volume in approximately an hour. Its IDANT division provides semen banking services, which include anonymous donor semen and semen storage; autologous blood storage; andrology services, which include semen analysis and sperm washing, and general lab testing.

Officers and directors

Michael Richard Feldschuh Chairman of the Board, President, Chief Executive Officer
Age: 47
Bio & Compensation  - Reuters
Jonathan Feldschuh Chief Scientific Officer, Director
Bio & Compensation  - Reuters
Edward Feuer Director
Bio & Compensation  - Reuters
James A. Lombard Independent Director
Age: 80
Bio & Compensation  - Reuters
Bernhard Saxe Esq. Independent Director
Age: 76
Bio & Compensation  - Reuters
Robert Willens Independent Director
Age: 69
Bio & Compensation  - Reuters
Martin S. Wolpoff Independent Director
Age: 72
Bio & Compensation  - Reuters